Increasing Demand for Micromobility Solutions Fueling Kick Scooter Sales

The increasing adoption of kick scooters in kick scooter sharing services is fueling their sales across the world. As compared to the other types of vehicles used by shared mobility service providers, electric kick scooters can be easily leveraged for solving the issue of last-mile connectivity and they can also be hyper-localized. Moreover, these vehicles are highly compact, easy to operate, and do not need any physical exertion, which further boost their popularity among shared mobility service providers. 

Additionally, many companies have started providing their scooter sharing services in different locations, which has also propelled the growth of the kick scooter market. For example, Sharing Muving SL, which is a Spanish electric scooter sharing company, announced in 2018 that it has started offering its service in Atlanta, the U.S. Furthermore, Neutron Holdings Inc., which operates under the name LimeBike, launched dockless electric kick scooters and bikes for sharing in many cities in the U.S. in 2017. 

Furthermore, the declining prices of these batteries are also boosting their sales across the world. Geographically, the demand for kick scooters is currently the highest in the Asia-Pacific (APAC) region, as per the observations of P&S Intelligence, a market research company based in India. This is attributed to the large-scale deployment of these scooters in China. The existence of many major electric kick scooter manufacturing companies, rapidly developing electric vehicle value chain, implementation of favorable government policies, availability of affordable batteries, and the presence of a large customer pool are the main factors propelling the sales of these vehicles in the country. 

Hence, the demand for kick scooters will surge sharply in the upcoming years, primarily because of their soaring adoption in shared mobility fleets, growing popularity of micromobility solutions, owing to the increasing road congestion levels, rising requirement for better last-mile connectivity, and falling prices of lithium-ion batteries all over the world. 

Read More

Small Joint Reconstructive Implants Market to Witness 5.5% CAGR during 2019–2024

According to the Global Burden of Disease Study, 2017, about 16% of disability cases were a result of musculoskeletal conditions, which is the second-largest cause of global disability. These conditions comprise more than 150 diagnoses that affect the bones, muscles, joints, and associated tissues — collectively referred to as the locomotor system. The most common and disabling musculoskeletal conditions are osteoarthritis and systemic inflammatory conditions, such as rheumatoid arthritis (RA). The prevalence of RA lies between 0.3 and 1%, and the condition more commonly affects females. Further, globally, symptomatic osteoarthritis affects 9.6% men and 18% women over 60 years of age.

Moreover, with aging, numerous changes occur in the cartilage and connective tissue. The joints become less resilient and more susceptible to damage due to the thinning of the cartilage and altering of its components (proteoglycans — supportive structures of the cartilage). This may either lead to osteoarthritis or stiffness in the joints; therefore, elderly people are more susceptible to such conditions as compared to young people. Many European countries, such as Italy, Germany, France, and Spain, are witnessing an increase in the geriatric population. This is resulting in the growing demand for diagnostic techniques and treatments for bone-related disorders. This factor, along with the rising prevalence of musculoskeletal diseases, is contributing to the increasing requirement for small joint reconstructive implants. 

Browse report overview and detailed TOC on Small Joint Reconstructive Implants Market Growth

The highest usage of small joint reconstructive implants was observed in the North American region, among all other regions, such as Middle East & Africa, Europe, Latin America, Europe, and Asia-Pacific (APAC), in the past. This was attributed to the well-established healthcare industry in the region, technological advancements, and high adoption rate of such implants. In the coming time, the fastest growth in demand for small joint reconstructive implants will be registered by the APAC region.

This can be ascribed to the sedentary lifestyle of people and growing incidents of road accidents. The World Health Organization reported that in China, road traffic injuries are the major cause of death of people in the 15–44 age group. Further, India is also witnessing a surge in road accidents, which is adding to the demand for joint implants in the region.

Read More

Stable Growth Predicted in Aspiration and Biopsy Needles Market in Coming Years

One of the most important factors leading to the rising demand for aspiration and biopsy needles is the increasing prevalence of cancer across the world. According to the World Health Organization (WHO), the number of people who died from cancer stood at 9.6 million in 2018. Furthermore, the number of people suffering from malignant tumors will increase from 12.7 million in 2008 to 21.4 million in 2030, which will considerably boost the demand for aspiration and biopsy needles, on account of the fact that biopsy and aspiration procedures are extensively used for studying the nature of tumors.

The other major factors contributing to the surge in the demand for aspiration and biopsy needles are the rising popularity of minimally invasive surgeries, soaring healthcare expenditure in several countries, and rapid technological innovations in the devices used for disease diagnosis. Due to these factors, the global aspiration and biopsy needles market size is predicted to increase from $801.5 million in 2019 to $1,717.9 million in 2030. The market is expected to progress at a CAGR of 7.2% during the forecast period (2020–2030).

For More Information Aspiration and Biopsy Needles Market Report 

Geographically, the highest usage of aspiration and biopsy needles was observed in North America in 2019, mainly due to the rising awareness in the region about the early cancer diagnosis processes, soaring healthcare spending, and surging number of devices being granted approval by the USFDA. The fastest growth in the adoption of aspiration and biopsy needles is expected to be witnessed in the Asia-Pacific (APAC) region during the forecast period. This is primarily ascribed to the increasing pool of cancer patients and rising awareness regarding the various cancer diagnosis methods available in the region.

Therefore, owing to the rising incidence of cancer, increasing healthcare expenditure, and surging awareness amongst the people throughout the world about the various cancer diagnosis processes, the demand for aspiration and biopsy needles will observe significant growth in future.

Read More

Demand for Radiotherapy Projected to Rise in Asia-Pacific

 The number of cancer cases has been rising all across the globe over the past few years. As per the American Institute of Cancer Research, by 2030, the number of new cancer incidence is expected to reach 25 million. The prevalence of cancer is further predicted to be the highest in low and middle-income countries, including India and China. Cancer is among the most common chronic diseases around the globe, and was responsible for 9.6 million deaths in 2018, as per the World Health Organization. 

The prevalence of cancer can be decreased by providing efficient medical care at initial stage of the disease, which can be done by radiotherapy and chemotherapy. Radiotherapy is majorly used for treating cancer, reducing the risk of cancer coming back if a person goes through surgery, and relieving symptoms if the patient cannot be cured. It is considered the most effective treatment for cancer, however, its effectiveness varies from person to person. According to a report by P&S Intelligence, the global radiotherapy market is expected to generate a revenue of $17,194.4 million by 2030, increasing from $7,222.4 million in 2019, advancing at an 8.4% CAGR during the forecast period (2020–2030).  

Other than this, the demand for radiotherapy is also predicted to rise in Asia-Pacific, thereby making the region the fastest-growing radiotherapy market in the coming years. This is because of the increasing burden of cancer, rising investments by private and public organizations, and improving healthcare infrastructure. As per the Global Cancer Observatory, in 2018, 883,395 cancer cases were reported in Japan, and the number is predicted to rise to 3.5 million by 2025. 

Hence, the market is growing due to the surging prevalence of cancer across the globe.   

Read More

Wireless EV Chargers Facilitating Hassle-Free Long Drives

The International Energy Agency (IEA) reveals that the global stock of plug-in hybrid vehicles (PHEVs) , battery electric vehicle (BEVs) , and fuel cell electric vehicle (FCEVs) stood at 3,346,713 units, 6, 850,327 units, and 31,225 units, respectively, in 2020. By 2030, the stock of PHEVs, FCEVs, and BEVs will rise to 44,355,904, 1,152,588, 79,975,992, respectively 2030. Whereas, the global stock of BEV and PHEV electric buses is expected to surge from 515,400 in 2020 to 3,217,713 by 2030 and 81,898 in 2020 to 358,921 by 2030, respectively.  

Wireless EV Charging Market Outlook

   

Thus, the surging adoption of EVs will augment the need for fast charging options, owing to which the wireless EV charging market will advance at a significant rate during 2020–2030. To establish a fast EV charging infrastructure, several charging station developers are focusing on investing in research and development (R&D) in wireless technology. The installation of dynamic wireless systems on EVs allows them to be charged while on the move. Moreover, the absence of charging cables in wireless systems makes it more user-friendly than cable charging systems.

According to P&S Intelligence, Asia-Pacific (APAC) will dominate the wireless EV charging market in the foreseeable future. This will be due to the escalating EV adoption in developing countries, such as India and China, and developed countries, such as Japan. In recent years, China has emerged as an active participant in the EV charging industry, due to the rapid development of advanced inductive chargers. For example, in 2016, Zhejiang VIE Science & Technology Co. Ltd. and Evatran Group Inc. formed a joint venture to integrate PLugless, a wireless charging system of the former, into the EVs being manufactured in China.

Thus, the soaring number of EVs, owing to the mounting environmental concerns and escalating government support, will augment the installation of wireless EV chargers in the forthcoming years. 

Explore Full Report Description At: https://www.psmarketresearch.com/market-analysis/wireless-ev-charging-market

 

Read More

Surging Healthcare Expenditure Powering Sales of Prostate Cancer Treatment Devices in U.S.

 The availability of automated, efficient, and advanced clinical tools and the emergence of extremely accurate forms of medical treatment such as image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), and brachytherapy are pushing up the demand for prostate cancer treatment devices in the U.S. For example, Accuray Incorporated developed CyberKnife S7 System, which is a device equipped with synchronization treatment delivery and real-time artificial intelligence (AI)-driven motion tracking for all stereotactic body radiation therapy (SBRT) and SRS treatments, in June 2020.

This device is the next-generation CyberKnife platform, which is a non-invasive and a robotic radiation therapy device that can treat benign and cancerous tumors all over the body, including those in prostate glands. The increasing incidence of prostate cancer is another major factor boosting the sales of prostate cancer treatment devices in the country. According to the American Cancer Society (ACS), one of the most prevalent types of cancers in male persons in the U.S. is prostate cancer. 

Additionally, the organization predicts that the country will witness as many as 191,930 new prostate cancer cases in 2020. With the increasing incidence of prostate cancer, the requirement for several types of treatment equipment such as those used in surgery, cryotherapy, and radiotherapy will surge in the coming years. The soaring number of government initiatives being launched and the surging healthcare expenditure in the country are also propelling the sales of prostate cancer treatment devices.  

The federal government spends a huge portion of the country’s GDP on healthcare every year. According to the National Health Expenditure Accounts (NHEA), in the U.S., the healthcare spending increased by 4.3% and reached $3.3 trillion in 2016. In 2017, the healthcare expenditure further rose to 5.4%. The increasing healthcare expenditure is making the management and treatment of many diseases highly affordable by reducing the prices of prostate cancer treatment devices.  

The mushrooming sales of these devices are fueling the growth of the U.S. prostate cancer treatment devices market. According to the estimates of the market research firm, P&S Intelligence, the valuation of the market would grow from $95.9 million in 2019 to $157.1 million by 2030. The market will demonstrate a CAGR of 5.6% from 2020 to 2030. Surgery, radiation, high-intensity focused ultrasound (HIFU), and cryotherapy are the main types of prostate cancer treatment devices used in the country. 

Read More

Why are Sales of Skincare Dermacosmetics Products Soaring in India?

India has witnessed rapid economic progress in recent years, which has subsequently resulted in a massive rise in the disposable income of its citizens. As per the data produced by Trading Economics, in India, the disposable income grew from $2,738.1 billion in 2018 to $2,935.9 billion in 2019. Moreover, with the country predicted to witness sharp economic growth in the coming years, the purchasing power of its citizens will further shoot up.

This will, in turn, propel the sales of skincare dermacosmetics products in the country in the coming years. Besides the increasing disposable income of people, the rising inclination of people for having a good physical appearance is also propelling the sales of skincare dermacosmetics products in the country. People are making huge investments for brightening and maintaining their skin and using products for mitigating the occurrence of acne marks and the signs of aging such as fine lines and wrinkles.

Furthermore, as per the estimates of the market research company, P&S Intelligence, the market will progress at a CAGR of 8.5% between 2020 and 2030. The major brands that sell skincare dermacosmetics products in the country are Neutrogena, Avène, L’Oréal (Skinceuticals and CeraVe), A-Derma, Galderma and Cetaphil, BIODERMA, Clinique, Sebamed, Ducray, Clarins, and Shiseido. Out of these, the demand for products developed by Avène was found to be the highest in the country in 2019. 

This was mainly because of the availability of a diverse range of products and patented technologies developed by the company for addressing various skin problems and concerns. The major application areas of skincare dermacosmetics products in the country are wrinkles and fine lines, acne, dark circles, skin repair, scars, and psoriasis. Out of these, skin repair applications are predicted to generate the highest demand for skincare dermacosmetics products in the coming years. 

Read More